New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


Biogen finalizes $900 mln drug kickback settlement, U.S. says

The lawsuit accused Biogen of directing millions of dollars in kickbacks to doctors to prescribe its MS drugs Avonex, Tysabri and Tecfidera from 2009 to 2014, with kickbacks delivered in the form of “sham” consulting deals and speaker programs as well as lavish dinners and entertainment.


Prosoma Digital Therapeutics and EVERSANA announce Commercialization partnership for new therapeutic supporting mental health and behavioral needs of cancer patients

On the heels of the upcoming major digital therapeutics show in Boston (DTx East), EVERSANA has announced a partnership with Warsaw, Poland-based Prosoma Digital Therapeutics. Together, they will work together to bring the company’s Living Well digital therapy to the U.S. to improve the quality of life and reduce stress, anxiety, and depression symptoms for patients related to a cancer diagnosis.